JPND held an industry consultation meeting on May 16th, 2011 at the University of Milan, Italy.

The consultation brought together representatives from biotechnology, biopharmaceutical and diagnostic companies with specific interest in the neurodegenerative diseases that fall within the focus of the JPND research agenda.

The aim of the meeting was to ascertain; the key priorities and needs of industries active in the field of ND, the “industry view” on the priorities identified by the academic sector through the thematic workshops, and the specific requirements for collaborative activity with the academic sector and other stakeholders (funders, regulators, etc.).

Download the summary report on the meeting findings here.

Chairperson: Adriana Maggi, MIUR, Italy

Presentations: Click on the presentation title to download the slides (pdf)

1. Introduction to JPND – Adriana Maggi

2. Developing the SRA – Catherine Moody

3. Outcomes of the Thematic Workshops – Adriana Maggi


Mohammad S. AlavijehManaging DirectorPharmidex Pharmaceutical Ltd UK
Mariangela AmorosoNeuroscience and Immunoscience Area HeadBristol Meyer Squibb
John R. AtackSenior Fellow, In Vitro NeuroscienceJanssen R&D, J&J Pharmaceutical
Roberta ButiGrant ManagerChiesi Farmaceutici
Stefano BruniScientific DirectorGenzyme
Carla CacciaGrant ManagerNewron Pharmaceuticals SpA
Donatella CrippaHead of Medical AffairsBayer Healthcare
Milva D’AroncoCountry Leader, Alzheimer’s DiseasePfizer, Italy
Daniele D’IlarioMedical & Scientific Relations CNS & PainPfizer, Italy
Béatrice DavidLatin Europe Sales ManagerCaliper Life Science
Grazia Dell’AgnelloMedical AdvisorLilly, Italy
Koen DewaeleAlzheimer’s Programme DirectorInnogenetics NV
Sophie DixSenior Research Scientist, ND Drug Hunting TeamLilly, UK
Bruno ImbimboHead, CNS ResearchChiesi Farmaceutici
Rainer KuhnHead of Neurodegeneration ResearchNovartis Pharma AG
Wally LandsbergEuropean Medical Lead, NeuroscienceBristol Meyer Squibb
Bertrand LoubatonDirector, Pharmaceutical & Academic Research Collaboration Academic ProgramsGE HealthCare
Fabio MaggioniDiagnostic Imaging Medical Science LiaisonBayer Healthcare
Gareth Maher-EdwardsDirector, Clinical DevelopmentGlaxoSmithKline
Francesco MonetaLead, Molecular Resonance ImagingBruker, Italy
Pierangelo MoriniDeputy AdministratorBruker, Italy
Francois NicolasBioSignature Technology LeaderGE HealthCare
Michael O’NeillSenior Research Advisor, ND Drug Hunting TeamLilly, UK
Jan Torleif PedersenSection head, BioinformaticsH. Lundbeck A/S
Thomas RooneyAgeing Therapeutic Strategic Unit, Head Translational Research GroupSanofi-Aventis
Patricia SalvatiVP Preclinical Research and DevelopmentNewron Pharmaceuticals SpA
Erik WongDirector, External Science CNS Pain Innovative Medicine UnitAstraZeneca Pharmaceuticals LP
Sean GreatbanksJPND Programme AdministratorMRC (UK)
Adriana MaggiJPND Executive Board Vice-Chair and Director, Centre of Excellence on NDD’s, MilanMIUR (Italy)
Catherine MoodyJPND Manager & Neurosciences and Mental Health Programme ManagerMRC (UK)
Micol ZappaJPND Programme ManagerMIUR (Italy)